The Section of Hematology has a strong Sickle Cell Program that follows approximately 300 patients with sickle cell. Our Hemophilia Treatment Center follows more than 300 patients annually Additionally, we have an excellent Coagulation/Thrombosis service that follows more than 500 patients with bleeding disorders.
- Our team collaborates with other specialists and research scientists across the U.S.
- Our staff leads cutting-edge research studies that are leading to better diagnosis and treatment for pediatric blood disorders.
- We provide specialized treatment and research opportunities for conditions such as pediatric hemophilia, hematological disorders, and sickle cell disease.
- Our LAUNCH program ensures a smooth transition for patients with bleeding disorders transitioning from pediatric to adult care.